TIBER CREEK GROUP

Lobbying for EMD SERONO, INC. · Biopharmaceuticals.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Oct 19, 2025

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to reproductive healthcare and IVF.

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.